Back

Disrupted oral microbial networks and reproducible community signatures implicate the oral-gut axis in Crohn's disease

Whelan, R. J.; Wands, D. I.; Rimmer, P.; Hansen, R.; Wilson, D. C.; Oral Microbiome data provision group, ; Gerasimidis, K.; Hold, G. L.; Chapple, I. L.; Iqbal, T.; Ho, G.-t.

2026-04-29 gastroenterology
10.64898/2026.04.28.26351936 medRxiv
Show abstract

BackgroundEmerging evidence suggests that the oral microbiome may contribute to aberrant gut immune responses in Inflammatory Bowel Disease (IBD). MethodsWe performed a comprehensive, harmonised analysis of aggregated oral microbiome 16S rRNA datasets across multiple cohorts. Data were processed using a unified bioinformatics pipeline including DADA2 for taxonomic assignment, PICRUSt2 for functional prediction, MaAsLin2 for multivariable modelling, and machine learning. ResultsAcross 25 studies (n = 1,136 IBD; n = 759 controls), meta-analysis showed significantly reduced oral microbial Shannon diversity in IBD (standardised mean difference -0.31, p = 0.007). Secondary bioinformatics analysis of six datasets plus in-house data confirmed this reduction (Shannon diversity; Hedges SMD = -0.372, p < 0.001), driven primarily by Crohns disease (CD). Beta diversity demonstrated global compositional shifts, with CD demonstrating greater divergence from controls than ulcerative colitis (UC). Multivariable modelling identified reproducible taxa enriched in IBD, including Corynebacterium, Serratia and Streptoccocus, while Porphyromonas and Ruminococcaceae.G1 were enriched in controls. Functional pathway prediction indicated reduced butyrate metabolism in IBD sub-types and increased aromatic amino acid and related metabolite degradation pathways. Machine learning classifiers achieved modest discrimination (mean AUC [~]0.67), supporting the potential of saliva-based microbiome profiling to study dysbiosis in IBD. ConclusionsThese findings demonstrate that the oral microbiome in IBD is characterised by reduced diversity and reproducible structural community reorganisation. Together, these data support a contributory role for the oral-gut axis in CD pathogenesis and provide a rationale for targeted mechanistic and longitudinal studies to define causal links between oral dysbiosis and intestinal inflammation. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/26351936v1_ufig1.gif" ALT="Figure 1"> View larger version (38K): org.highwire.dtl.DTLVardef@57306corg.highwire.dtl.DTLVardef@2c0ef0org.highwire.dtl.DTLVardef@88b0b3org.highwire.dtl.DTLVardef@8ed62_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Inflammatory Bowel Diseases
15 papers in training set
Top 0.1%
26.5%
2
Gut Microbes
70 papers in training set
Top 0.1%
12.6%
3
mSystems
361 papers in training set
Top 0.6%
10.7%
4
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.1%
5.0%
50% of probability mass above
5
Microbiome
139 papers in training set
Top 0.8%
4.1%
6
mBio
750 papers in training set
Top 5%
2.8%
7
Gut
36 papers in training set
Top 0.3%
2.5%
8
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 2%
2.1%
9
Immunology & Cell Biology
11 papers in training set
Top 0.1%
1.9%
10
Gastroenterology
40 papers in training set
Top 0.9%
1.9%
11
BMC Medicine
163 papers in training set
Top 3%
1.9%
12
American Journal of Gastroenterology
15 papers in training set
Top 0.2%
1.7%
13
Journal of Cystic Fibrosis
15 papers in training set
Top 0.1%
1.7%
14
Nature Communications
4913 papers in training set
Top 52%
1.7%
15
Frontiers in Pharmacology
100 papers in training set
Top 3%
1.0%
16
Science Translational Medicine
111 papers in training set
Top 4%
1.0%
17
Scientific Reports
3102 papers in training set
Top 70%
0.9%
18
Frontiers in Medicine
113 papers in training set
Top 5%
0.9%
19
eBioMedicine
130 papers in training set
Top 3%
0.9%
20
Cell Reports Medicine
140 papers in training set
Top 6%
0.9%
21
Frontiers in Immunology
586 papers in training set
Top 7%
0.8%
22
The Journal of Infectious Diseases
182 papers in training set
Top 5%
0.8%
23
Metabolites
50 papers in training set
Top 1%
0.8%
24
Frontiers in Physiology
93 papers in training set
Top 7%
0.7%
25
Journal of Clinical Immunology
11 papers in training set
Top 0.2%
0.7%
26
PLOS ONE
4510 papers in training set
Top 72%
0.5%
27
Journal of Proteomics
27 papers in training set
Top 0.6%
0.5%